IBIO, INC. Shareholders' Equity
IBIO, INC. (IBIO) had Shareholders' Equity of $85.71 million as of 2026-06-30, per its 10-K filed 2026-08-28.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-28
- 2026-06-30: Stockholders' Equity Attributable to Parent $85.71M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $77.54M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $56.56M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $56.04M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $85.71M 10-K · filed 2026-08-28 | |
| 2026-03-31 | $77.54M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $56.56M 10-Q · filed 2026-02-10 | |
| 2025-09-30 | $56.04M 10-Q/A · filed 2025-11-17 | |
| 2025-06-30 | $14.88M 10-K · filed 2026-08-28 | |
| 2025-03-31 | $11.38M 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $13.89M 10-Q · filed 2025-02-10 | |
| 2024-09-30 | $17.75M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $21.32M 10-K · filed 2025-09-05 | |
| 2024-03-31 | $24.86M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $9.20M 10-Q · filed 2024-02-09 | |
| 2023-09-30 | $13.21M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $15.38M 10-K/A · filed 2024-09-24 | |
| 2023-03-31 | $17.39M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $18.82M 10-Q/A · filed 2023-05-19 | |
| 2022-09-30 | $48.37M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $63.48M 10-K · filed 2023-09-27 | |
| 2022-03-31 | $79.38M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $90.60M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $100.54M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $108.58M 10-K · filed 2022-10-11 | |
| 2021-03-31 | $104.84M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $107.33M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $80.05M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $56.62M 10-K · filed 2021-09-28 | |
| 2020-03-31 | $3.97M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | -$511.00K 10-Q · filed 2020-02-14 | |
| 2019-09-30 | -$1.93M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $2.46M 10-K · filed 2020-10-13 | |
| 2019-03-31 | $6.91M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $11.08M 10-Q · filed 2019-02-13 | |
| 2018-09-30 | $13.03M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $16.17M 10-K · filed 2019-08-26 | |
| 2018-03-31 | $4.15M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $7.81M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $6.29M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $8.91M 10-K · filed 2018-09-18 | |
| 2017-03-31 | $12.95M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $4.15M 10-Q · filed 2017-02-21 | |
| 2016-09-30 | $7.14M 10-Q · filed 2016-11-18 | |
| 2016-06-30 | $9.94M 10-K · filed 2017-09-15 | |
| 2016-03-31 | $8.27M 10-Q · filed 2016-05-23 | |
| 2015-12-31 | $7.88M 10-Q · filed 2016-02-22 | |
| 2015-09-30 | $9.81M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $11.23M 10-K · filed 2016-10-13 | |
| 2015-03-31 | $10.19M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $9.57M 10-Q · filed 2015-02-24 | |
| 2014-09-30 | $5.44M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $6.10M 10-K · filed 2015-10-13 | |
| 2014-03-31 | $7.00M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $7.95M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $5.68M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $5.07M 10-K · filed 2015-10-13 | |
| 2013-03-31 | $2.30M 10-Q · filed 2013-05-20 | |
| 2012-12-31 | $3.72M 10-Q · filed 2013-02-19 | |
| 2012-09-30 | $4.57M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $6.17M 10-K · filed 2014-09-29 | $6.17M 10-K/A · filed 2012-10-15 |
| 2012-03-31 | $6.85M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $305.48K 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $886.10K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $196.00K 10-K/A · filed 2013-10-04 | $196.64K 10-Q · filed 2011-11-14 |
| 2010-06-30 | $1.08M 10-K/A · filed 2012-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |